Tamoxifen Is an Estrogen Antagonist on Gonadotropin Secretion and Responsiveness of the Hypothalamic-Pituitary-Adrenal Axis in Female Monkeys

Endocrine

Volumn 22, Issue 3, 2003, Pages 305-315

  Wilson, M E ^a   Mook, D ^b,c   Graves, F ^a,d   Felger, J ^a   Bielsky, I F ^a   Wallen, K ^a,d  

^a EMORY UNIVERSITY   (United States)

^b Division of Animal Resources   (United States)

^c Department of Pathology   (United States)

^d Department of Psychology ^*  (United States)

Author keywords

ACTH; Corticotropin releasing hormone; Cortisol; Dexamethasone; Estradiol; LH; SERM; Tamoxifen

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; ESTRADIOL; GONADOTROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; PLACEBO; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICOTROPIN RELEASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MEGADOSE; ESTROGEN THERAPY; FEMALE; FEMALE GENITAL SYSTEM; GONADOTROPIN RELEASE; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERMETHOD COMPARISON; LUTEINIZING HORMONE RELEASE; MACACA; MEDICAL ASSESSMENT; NEGATIVE FEEDBACK; NERVE CELL NETWORK; NEUROENDOCRINE SYSTEM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RANDOMIZATION; SPECIES COMPARISON;

EID: 0842334762     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:22:3:305     Document Type: Article

References (104)

1. Cosman, F. and Lindsay, R. (1999). Endocrine Rev. 20, 418-434.
2. Dardes, R. C. and Jordan, V. C. (2000). Br. Med. Bull. 56, 773-786.
3. Knobil, E. (1988). Hum. Reprod. 3, 469-472.
4. Overlie, I., Moen, M. H., Morkrid, L., Skjaeraasen, J. S., and Holte, A. (1999). Acta Obstet. Gynecol. Scand. 78, 642-647.
5. Urshiroyama, T. and Sugimoto, O. (1995). Horm. Res. 44, 64-68.
6. Longcope, C. (2001). J. Soc. Gynecol. Investig. 8, S67-S68.
7. Sluijmer, A. V., Heineman, M. J., De Jong, F. H., and Evers, J. L. (1995). J. Clin. Endocrinol. Metab. 80, 2163-2167.
8. Jordan, V. C., Fritz, N. F., and Tormey, D. C. (1987). Cancer Res. 47, 624-630.
9. Ravdin, P. M., Fritz, N. F., Tormey, D. C., and Jordan, V. C. (1988). Cancer Res. 48, 1026-1029.
10. Welt, C. K., Pagan, Y. L., Smith, P. C., Rado, K. B., and Hall, J. E. (2003). J. Clin. Endocrinol. Metab. 88, 1766-1771.
11. Boostanfar, R., Jain, J. K., Mishell, D. R. Jr. and Paulson, R. J. (2001). Fert. Steril. 75, 1024-1026.
12. Suginami, H., Kitagawa, H., Nakahashi, N., Yano, K., and Matsubara, K. (1993). Fertil. Steril. 59, 976-979.
13. Robertson, J. F. and Blarney, R. W. (2003). Eur. J. Cancer 39, 861-869.
14. Goss, P. E., Clark, R. M., Ambus, U., et al. (1995). Clin. Cancer Res. 1, 287-294.
15. Donath, J. and Nishino, Y. (1998). J. Steroid Biochem. Mol. Biol. 66, 247-254.
16. Sanchez-Criado, J. E., Guelmes, P., Bellido, C., et al. (2002). Neuroendocrinology 76, 203-213.
17. Gao, X., Petroff, B. K., Oluola, O., Georg, G., Terranova, P. F., and Rozman, K. K. (2002). Toxicol. Appl. Pharmacol. 183, 179-188.
18. Paterson, A. G., Turkes, A., Groom, G. V., and Webster, D. J. (1983). Eur. J. Cancer Clin. Oncol. 19, 919-922.
19. Luciani, L., Oriana, S., Spatti, G., et al. (1984). Tumori 70, 189-192.
20. Alexieva-Figusch, J., Blankenstein, M. A., de Jong, F. H., and Lamberts, S. W. (1984). Eur. J. Cancer Clin. Oncol. 20, 135-140.
21. Gasparini, G., Canobbio, L., Galligioni, E., et al. (1987). Eur. J. Cancer Clin. Oncol. 23, 1451-1459.
22. Miodrag, A., Ekelund, P., Burton, R., and Castleden, C. M. (1991). Age Ageing 20, 52-54.
23. Lonning, P. E., Johannessen, D. C., Lien, E. A., Ekse, D., Fotsis, T., and Adlercreutz, H. (1995). J. Steroid Biochem. Mol. Biol. 52, 491-496.
24. Kostoglou-Athanassiou, I., Ntalles, K., Gogas, J., et al. (1997). Horm. Res. 47, 116-120.
25. Kavak, Z. N., Binoz, S., Ceyhan, N., and Pekin, S. (2000). Acta Obstet. Gynecol. Scand. 79, 604-607.
26. Harper-Wynne, C. L., Sacks, N. P., Shenton, K., et al. (2002). J. Clin. Oncol. 20, 1026-1035.
27. De Marinis, L., Mancini, A., Izzi, D., et al. (2000). Clin. Endocrinol. 52, 681-685.
28. Patchev, V. K. and Almeida, O. F. (1996). J. Neurosci. 16, 7077-7084.
29. Dayas, C. V., Xu, Y., Buller, K. M., and Day, T. A. (2000). J. Neuroendocrinol. 12, 784-794.
30. Roy, B. N., Reid, R. L., and Van Vugt, D. A. (1999). Endocrinology 140, 2191-2198.
31. Vamvakopoulos, N. C. and Chrousos, G. P. (1993). J. Clin. Invest. 92, 1896-1902.
32. Kerdelhue, B., Jones, G. S., Gordon, K., et al. (1995). J. Neurosci. Res. 42, 228-235.
33. Carey, M. P., Deterd, C. H., de Koning, J., Helmerhorst, F., and de Kloet, E. R. (1995). J. Endocrinol. 144, 311-321.
34. Smith, C. J. and Norman, R. L. (1987). Endocrinology 121, 2192-2198.
35. Giussani, D. A., Farber, D. M., Jenkins, S. L., et al. (2000). Biol. Reprod. 62, 1445-1451.
36. Gudmundsson, A., Goodman, B., Lent, S., et al. (1999). Exp. Gerontol. 34, 809-818.
37. Fonseca, E., Basurto, L., Velazquez, S., and Zarate, A. (2001). Maturitas 39, 57-62.
38. De Leo, V., la Marca, A., Talluri, B., D'Antona, D., and Morgante, G. (1998). Eur. J. Endocrinol. 138, 430-435.
39. Grino, M., Hery, M., Paulmyer-Lacroix, O., and Anglade, G. (1995). Endocrine 3, 395-398.
40. Figueiredo, H. F., Dolgas, C. M., and Herman, J. P. (2002). Endocrinology 143, 2534-2540.
41. Young, E. A., Altemus, M., Parkison, V., and Shastry, S. (2001). Neuropsychopharmacology 25, 881-891.
42. de Vries, G. J. and Miller, M. A. (1998). Prog. Brain Res. 119, 3-20.
43. van Leeuwen, F. W., Caffe, A. R., and De Vries, G. J. (1985). Brain Res. 325, 391-394.
44. Wood, C. E., Saoud, C. J., Stoner, T. A., and Keller-Wood, M. (2001). Reg. Peptides 98, 63-68.
45. Kailajarvi, M., Ahokoski, O., Virtanen, A., Salminen, E., and Irjala, K. (2000). Anticancer Res. 20, 1323-1327.
46. van der Pompe, G., Antoni, M. H., and Heijnen, C. J. (1996). Psychoneuroendocrinology 21, 361-374.
47. Gilardi, K. V., Shideler, S. E., Valverde, C. R., Roberts, J. A., and Lasley, B. L. (1997). Biol. Reprod. 57, 335-340.
48. Holsboer, F., Grasser, A., Friess, E., and Wiedemann, K. (1994). Ann. NY Acad. Sci. 746, 345-359; discussion 359-361.
49. Newport, D. J., Heim, C., Owens, M. J., et al. (2003). Neuropsychopharmacology 28, 569-576.
50. Walker, M. L., Gordon, T. P., and Wilson, M. E. (1982). J. Med. Primatol. 11, 291-302.
51. Blank, M. S., Gordon, T. P., and Wilson, M. E. (1983). Acta Endocrinol. (Copenh.) 102, 190-195.
52. Wilson, M. E., Gordon, T. P., and Collins, D. C. (1986). Endocrinology 118, 293-301.
53. Tess, D. A., Cole, R. O., and Toler, S. M. (1995). J. Chromatogr. B Biomed. Appl. 674, 253-260.
54. Rossmanith, W. G., Scherbaum, W. A., and Lauritzen, C. (1991). Neuroendocrinology 54, 211-218.
55. Kwekkeboom, D. J., de Jong, F. H., van Hemert, A. M., Vandenbroucke, J. P., Valkenburg, H. A., and Lamberts, S. W. (1990). J. Clin. Endocrinol. Metab. 70, 944-950.
56. Hall, J. E., Lavoie, H. B., Marsh, E. E., and Martin, K. A. (2000). J. Clin. Endocrinol. Metab. 85, 1794-1800.
57. Lambalk, C. B., de Boer, L., Scheute, E., Popp-Snyders, C., and Schoemaker, J. (1997). Clin. Endocrinol. (Oxf.) 46, 439-443.
58. Gill, S., Sharpless, J. L., Rado, K., and Hall, J. E. (2002). J. Clin. Endocrinol. Metab. 87, 2290-2296.
59. Chongthammakun, S. and Terasawa, E. (1993). Endocrinology 132, 735-743.
60. Lagrange, A. H., Ronnekleiv, O. K., and Kelly, M. J. (1995). Endocrinology 136, 2341-2344.
61. Legan, S. J. and Callahan, W. H. (1999). Neuroendocrinology 70, 237-245.
62. Wagner, E. J., Ronnekleiv, O. K., Bosch, M. A., and Kelly, M. J. (2001). J. Neurosci. 21, 2085-2093.
63. Chappel, S. C., Resko, J. A., Norman, R. L., and Spies, H. G. (1981). J. Clin. Endocrinol. Metab. 52, 1-8.
64. Attardi, B., Hotchkiss, J., and Knobil, E. (1980). Nature 285, 252-254.
65. Plant, T. M., Nakai, Y., Belchetz, P., Keogh, E., and Knobil, E. (1978). Endocrinology 102, 1015-1018.
66. Couse, J. F. and Korach, K. S. (1999). Endocr. Rev. 20, 358-417.
67. Wersinger, S. R., Haisenleder, D. J., Lubahn, D. B., and Rissman, E. F. (1999). Endocrine 11, 137-143.
68. Lindzey, J., Wetsel, W. C., Couse, J. F., Stoker, T., Cooper, R., and Korach, K. S. (1998). Endocrinology 139, 4092-4101.
69. Shively, C. A., Williams, J. K., Laber-Laird, K., and Anton, R. F. (2002). Psychosom. Med. 64, 699-706.
70. Handa, R. J., Burgess, L. H., Kerr, J. E., and O'Keefe, J. A. (1994). Horm. Behav. 28, 464-476.
71. McCormick, C. M., Linkroum, W., Sallinen, B. J., and Miller, N. W. (2002). Stress 5, 235-247.
72. Koolhaas, J. M., Korte, S. M., De Boer, S. F., et al. (1999). Neurosci. Biobehav. Rev. 23, 925-935.
73. Palanza, P., Gioiosa, L., and Parmigiani, S. (2001). Physiol. Behav. 73, 411-420.
74. Heim, C., Owens, M. J., Plotsky, P. M., and Nemeroff, C. B. (1997). Psychopharmacol. Bull. 33, 185-192.
75. Scott, L. V. and Dinan, T. G. (2002). J. Affect. Disord. 12, 113-124.
76. Patchev, V. K. and Almeida, O. F. (1998). Mol. Neurobiol. 16, 63-77.
77. Shupnik, M. A. (2002). J. Neuroendocrinol. 14, 85-94.
78. Givalois, L., Li, S., and Pelletier, G. (1999). J. Endocrinol. 161, 307-316.
79. Aguilera, G., Rabadan-Diehl, C., and Nikodemova, M. (2001). Peptides 22, 769-774.
80. Torpy, D. J., Grice, J. E., Hockings, G. I., Walters, M. M., Crosbie, G. V., and Jackson, R. V. (1994). J. Clin. Endocrinol. Metab. 79, 140-144.
81. Keck, M. E., Wigger, A., Welt, T., et al. (2002). Neuropsychopharmacology 26, 94-105.
82. Hrabovszky, E., Kallo, I., Hajszan, T., Shughrue, P. J., Merchenthaler, I., and Liposits, Z. (1998). Endocrinology 139, 2600-2604.
83. Alves, S. E., Lopez, V., McEwen, B. S., and Weiland, N. G. (1998). Proc. Natl. Acad. Sci. USA 95, 3281-3286.
84. Nomura, M., McKenna, E., Korach, K. S., Pfaff, D. W., and Ogawa, S. (2002). Brain Res. Mol. Brain Res 109, 84-94.
85. Thomas, A., Kim, N. B., and Amico, J. A. (1996). Brain Res. 738, 48-52.
86. Hashimoto, K., Ohno, N., Aoki, Y., Kageyama, J., Takahara, J., and Ofuji, T. (1981). Acta Med. Okayama 35, 37-43.
87. Shughrue, P. J., Komm, B., and Merchenthaler, I. (1996). Steroids 61, 678-681.
88. Shughrue, P. J., Scrimo, P. J., and Merchenthaler, I. (1998). Endocrinology 139, 5267-5270.
89. Scott, L. V. and Dinan, T. G. (1998). Life Sci. 62, 1985-1998.
90. Dobson, H., Ghuman, S., Prabhakar, S., and Smith, R. (2003). Reproduction 125, 151-163.
91. Pacak, K. and Palkovits, M. (2001). Endocr. Rev. 22, 502-548.
92. Herman, J. P., Tasker, J. G., Ziegler, D. R., and Cullinan, W. E. (2002). Pharmacol. Biochem. Behav. 71, 457-468.
93. Koob, G. F. (1999). Biol. Psychiatry 46, 1167-1180.
94. Patisaul, H. B., Aultman, E. A., Bielsky, I. R., Young, L. J., and Wilson, M. E. (2003). Brain Res. 987, 185-193.
95. Patisaul, H. B., Melby, M., Whitten, P. L., and Young, L. J. (2002). Endocrinology 143, 2189-2197.
96. Ni, X., Nicholson, R. C., King, B. R., Chan, E. C., Read, M. A., and Smith, R. (2002). J. Clin. Endocrinol. Metab. 87, 3774-3778.
97. Paech, K., Webb, P., Kuiper, G. G., et al. (1997). Science 277, 1508-1510.
98. Shang, Y. and Brown, M. (2002). Science 295, 2465-2468.
99. Shapiro, R. A., Xu, C., and Dorsa, D. M. (2000). Endocrinology 141, 4056-4064.
100. Luecken, L. J. and Compas, B. E. (2002). Ann. Behav. Med. 24, 336-344.
101. Sephton, S. E., Sapolsky, R. M., Kraemer, H. C., and Spiegel, D. (2000). J. Natl. Cancer Inst. 92, 994-1000.
102. Gold, S. M., Zakowski, S. G., Valdimarsdottir, H. B., and Bovbjerg, D. H. (2003). Psychoneuroendocrinology 28, 584-593.
103. McEwen, B. S. (1998). Ann. NY Acad. Sci. 840, 33-44.
104. McEwen, B. S. (2000). Brain Res. 886, 172-189.